Literature DB >> 22561824

Shedding pounds after going under the knife: metabolic insights from cutting the gut.

Keval Chandarana1, Rachel L Batterham.   

Abstract

Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery-a surgical method to reduce or modify the gastrointestinal tract-was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561824     DOI: 10.1038/nm.2748

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  16 in total

Review 1.  Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients.

Authors:  Richdeep S Gill; Shahzeer Karmali; Arya M Sharma
Journal:  Obesity (Silver Spring)       Date:  2010-10-21       Impact factor: 5.002

Review 2.  Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.

Authors:  William R Scott; Rachel L Batterham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

3.  Bariatric surgery and long-term cardiovascular events.

Authors:  Lars Sjöström; Markku Peltonen; Peter Jacobson; C David Sjöström; Kristjan Karason; Hans Wedel; Sofie Ahlin; Åsa Anveden; Calle Bengtsson; Gerd Bergmark; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Kristina Narbro; Ingmar Näslund; Torsten Olbers; Per-Arne Svensson; Lena M S Carlsson
Journal:  JAMA       Date:  2012-01-04       Impact factor: 56.272

4.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

5.  First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass.

Authors:  Matthew M Hutter; Bruce D Schirmer; Daniel B Jones; Clifford Y Ko; Mark E Cohen; Ryan P Merkow; Ninh T Nguyen
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

6.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

Authors:  Adam P Chambers; Lene Jessen; Karen K Ryan; Stephanie Sisley; Hilary E Wilson-Pérez; Margaret A Stefater; Shrawan G Gaitonde; Joyce E Sorrell; Mouhamadoul Toure; Jose Berger; David A D'Alessio; Stephen C Woods; Randy J Seeley; Darleen A Sandoval
Journal:  Gastroenterology       Date:  2011-07-12       Impact factor: 22.682

Review 7.  Changes in ghrelin levels following bariatric surgery: review of the literature.

Authors:  Kevin Tymitz; Amy Engel; Sarah McDonough; Mary Pat Hendy; George Kerlakian
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

8.  Long-term persistence of hormonal adaptations to weight loss.

Authors:  Priya Sumithran; Luke A Prendergast; Elizabeth Delbridge; Katrina Purcell; Arthur Shulkes; Adamandia Kriketos; Joseph Proietto
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

9.  Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.

Authors:  Blanca Oliván; Julio Teixeira; Mousumi Bose; Baani Bawa; Tangel Chang; Heather Summe; Hongchan Lee; Blandine Laferrère
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

10.  Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.

Authors:  Keval Chandarana; Cigdem Gelegen; Efthimia Karra; Agharul I Choudhury; Megan E Drew; Veronique Fauveau; Benoit Viollet; Fabrizio Andreelli; Dominic J Withers; Rachel L Batterham
Journal:  Diabetes       Date:  2011-02-03       Impact factor: 9.461

View more
  16 in total

1.  Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) Trial: Results at 1 Year.

Authors:  Clifford R Weiss; Godwin O Abiola; Aaron M Fischman; Lawrence J Cheskin; Jay Vairavamurthy; Brian P Holly; Olaguoke Akinwande; Franklin Nwoke; Kalyan Paudel; Stephen Belmustakov; Kelvin Hong; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Richard E Thompson; Taylor Dunklin; Harvey Ziessman; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2019-04-02       Impact factor: 11.105

2.  Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.

Authors:  Clifford R Weiss; Olaguoke Akinwande; Kaylan Paudel; Lawrence J Cheskin; Brian Holly; Kelvin Hong; Aaron M Fischman; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Kristen Kaiser; Amie Park; David M Shade; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2017-02-14       Impact factor: 11.105

3.  Bariatric Arterial Embolization: Effect of Microsphere Size on the Suppression of Fundal Ghrelin Expression and Weight Change in a Swine Model.

Authors:  Yingli Fu; Clifford R Weiss; Kalyan Paudel; Eun-Ji Shin; Dorota Kedziorek; Aravind Arepally; Robert A Anders; Dara L Kraitchman
Journal:  Radiology       Date:  2018-07-10       Impact factor: 11.105

4.  Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery.

Authors:  J C Bunt; R Blackstone; M S Thearle; K L Vinales; S Votruba; J Krakoff
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

Review 5.  Bariatric embolization of the gastric arteries for the treatment of obesity.

Authors:  Clifford R Weiss; Andrew J Gunn; Charles Y Kim; Ben E Paxton; Dara L Kraitchman; Aravind Arepally
Journal:  J Vasc Interv Radiol       Date:  2015-03-14       Impact factor: 3.464

6.  Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats.

Authors:  A R Ramzy; S Nausheen; P K Chelikani
Journal:  Int J Obes (Lond)       Date:  2013-10-29       Impact factor: 5.095

Review 7.  Unraveling oxyntomodulin, GLP1's enigmatic brother.

Authors:  Alessandro Pocai
Journal:  J Endocrinol       Date:  2012-09-27       Impact factor: 4.286

8.  Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption.

Authors:  Christian Ferdinand Jurowich; Christoph Otto; Prashanth Reddy Rikkala; Nicole Wagner; Ivana Vrhovac; Ivan Sabolić; Christoph-Thomas Germer; Hermann Koepsell
Journal:  J Diabetes Res       Date:  2015-06-22       Impact factor: 4.011

9.  Q&A: insulin secretion and type 2 diabetes: why do β-cells fail?

Authors:  James Cantley; Frances M Ashcroft
Journal:  BMC Biol       Date:  2015-05-16       Impact factor: 7.431

10.  Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance.

Authors:  Keval Chandarana; Cigdem Gelegen; Elaine E Irvine; Agharul I Choudhury; Chloé Amouyal; Fabrizio Andreelli; Dominic J Withers; Rachel L Batterham
Journal:  Mol Metab       Date:  2013-03-14       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.